Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID‑19 (Review)-Reference-Cited by-同舟云学术

Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID‑19 (Review)

Published:2022-04-12 Issue:6 Volume:23 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Baroiu Liliana¹,Anghel Lucreția¹,Tatu Alin¹,Iancu Alina²,Dumitru Caterina³,Leșe Ana-Cristina⁴,Drăgănescu Miruna¹,Năstase Florentina⁵,Niculeț Elena⁶,Fotea Silvia¹,Nechita Aurel¹,Voinescu Doina¹,Stefanopol Anca⁶

Affiliation:

1. Department of Clinical Medicine, Faculty of Medicine and Pharmacy, ‘Dunărea de Jos’ University, 800216 Galati, Romania

2. Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, ‘Dunărea de Jos’ University, 800216 Galati, Romania

3. Department of Laboratory Medicine, ‘Sf. Cuv. Parascheva’ Clinical Infectious Diseases Hospital, 800179 Galati, Romania

4. Faculty of Visual Arts and Design, ‘George Enescu’ National University of Arts, 700451 Iasi, Romania

5. Department of Neuropsychomotor Rehabilitation, ‘Sf. Ioan’ Clinical Hospital for Children, 800487 Galati, Romania

6. Multidisciplinary Integrated Center of Dermatological Interface Research, ‘Dunărea de Jos’ University, 800008 Galați, Romania

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference60 articles.

1. Dexamethasone in hospitalized patients with Covid-19;Horby;N Engl J Med,2021

2. Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy;Rodríguez-Tajes;J Viral Hepat,2021

3. COVID-19 induced hepatitis B virus reactivation: A novel case from the United Arab Emirates;Aldhaleei;Cureus,2020

4. COVID-19 impact on the liver;Baroiu;World J Clin Cases,2021

5. Effectiveness of 8- and 12-week treatment with ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naïve HCV patients in a real-life setting in Romania: The AMETHYST study;Trifan;J Gastrointestin Liver Dis,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future;Journal of Clinical Medicine;2024-04-02

2. Reactivación y coinfecciones virales en COVID-19: otro elemento a considerar. Revisión Sistemática;Kasmera;2023-09-19

3. Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19;Microbiology Spectrum;2023-08-17

4. Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?;Livers;2023-07-25

5. COVID-19 and liver injury: An ongoing challenge;World Journal of Gastroenterology;2023-01-14